Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

107 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Temozolomide as prophylaxis for melanoma brain metastases.
Conill C, González-Cao M, Jorcano S, Puig S, Malvehy J, Martí R, Castel T. Conill C, et al. Melanoma Res. 2004 Feb;14(1):73-4. doi: 10.1097/00008390-200402000-00012. Melanoma Res. 2004. PMID: 15091198 Clinical Trial. No abstract available.
Palbociclib combined with endocrine therapy in heavily pretreated HR+/HER2- advanced breast cancer patients: Results from the compassionate use program in Spain (PALBOCOMP).
Manso L, Hernando C, Galán M, Oliveira M, Cabrera MA, Bratos R, Rodríguez CA, Ruiz-Borrego M, Blanch S, Llombart-Cussac A, Delgado-Mingorance JI, Álvarez-Busto I, Gallegos I, González-Cortijo L, Morales S, Aguirre E, Hernando BA, Ballesteros A, Alés-Martínez JE, Reboredo C, Oltra A, González-Cao M, Santisteban M, Malón D, Echeverría I, García-Garre E, Vega E, Servitja S, Andrés R, Robles CE, López R, Galve E, Echarri MJ, Legeren M, Moreno F. Manso L, et al. Breast. 2020 Dec;54:286-292. doi: 10.1016/j.breast.2020.11.005. Epub 2020 Nov 13. Breast. 2020. PMID: 33242755 Free PMC article.
Adaptive resistance to targeted therapies in cancer.
Rosell R, Karachaliou N, Morales-Espinosa D, Costa C, Molina MA, Sansano I, Gasco A, Viteri S, Massuti B, Wei J, González Cao M, Martínez Bueno A. Rosell R, et al. Transl Lung Cancer Res. 2013 Jun;2(3):152-9. doi: 10.3978/j.issn.2218-6751.2012.12.08. Transl Lung Cancer Res. 2013. PMID: 25806228 Free PMC article. Review.
BRAF mutation analysis in circulating free tumor DNA of melanoma patients treated with BRAF inhibitors.
Gonzalez-Cao M, Mayo-de-Las-Casas C, Molina-Vila MA, De Mattos-Arruda L, Muñoz-Couselo E, Manzano JL, Cortes J, Berros JP, Drozdowskyj A, Sanmamed M, Gonzalez A, Alvarez C, Viteri S, Karachaliou N, Martin Algarra S, Bertran-Alamillo J, Jordana-Ariza N, Rosell R. Gonzalez-Cao M, et al. Melanoma Res. 2015 Dec;25(6):486-95. doi: 10.1097/CMR.0000000000000187. Melanoma Res. 2015. PMID: 26366702
Advances in immunotherapy for treatment of lung cancer.
Bustamante Alvarez JG, González-Cao M, Karachaliou N, Santarpia M, Viteri S, Teixidó C, Rosell R. Bustamante Alvarez JG, et al. Cancer Biol Med. 2015 Sep;12(3):209-22. doi: 10.7497/j.issn.2095-3941.2015.0032. Cancer Biol Med. 2015. PMID: 26487966 Free PMC article. Review.
Predictive factors for immunotherapy in melanoma.
Teixidó C, González-Cao M, Karachaliou N, Rosell R. Teixidó C, et al. Ann Transl Med. 2015 Sep;3(15):208. doi: 10.3978/j.issn.2305-5839.2015.05.07. Ann Transl Med. 2015. PMID: 26488004 Free PMC article. Review.
107 results